vs
Side-by-side financial comparison of Avidia Bancorp, Inc. (AVBC) and Xilio Therapeutics, Inc. (XLO). Click either name above to swap in a different company.
Avidia Bancorp, Inc. is the larger business by last-quarter revenue ($26.8M vs $13.7M, roughly 2.0× Xilio Therapeutics, Inc.). Xilio Therapeutics, Inc. runs the higher net margin — 75.7% vs 22.9%, a 52.8% gap on every dollar of revenue. Avidia Bancorp, Inc. produced more free cash flow last quarter ($24.1M vs $-2.1M).
Avidia Bank is an American mutual community bank headquartered in Hudson, Massachusetts. It was founded in 2007 when it was formed by a merger between Hudson Savings Bank and Westborough Bank.
Xilio Therapeutics is a clinical-stage biotechnology company dedicated to developing novel tumor-selective immunotherapies for cancer treatment. Its product pipeline features candidates engineered to trigger anti-tumor immune responses specifically inside tumor microenvironments, reducing systemic toxicities, and it primarily targets oncology patient populations in North America and other global markets.
AVBC vs XLO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $26.8M | $13.7M |
| Net Profit | $5.3M | $10.4M |
| Gross Margin | — | — |
| Operating Margin | 33.3% | -86.5% |
| Net Margin | 22.9% | 75.7% |
| Revenue YoY | — | — |
| Net Profit YoY | — | 179.1% |
| EPS (diluted) | — | $-3.74 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $26.8M | $13.7M | ||
| Q3 25 | $28.0M | $19.1M | ||
| Q2 25 | $25.9M | $8.1M | ||
| Q1 25 | $22.9M | $2.9M |
| Q4 25 | $5.3M | $10.4M | ||
| Q3 25 | $-907.0K | $-16.3M | ||
| Q2 25 | $3.9M | $-15.8M | ||
| Q1 25 | $-11.6M | $-13.3M |
| Q4 25 | 33.3% | -86.5% | ||
| Q3 25 | -7.0% | -10.1% | ||
| Q2 25 | 19.4% | -177.7% | ||
| Q1 25 | -72.0% | -472.7% |
| Q4 25 | 22.9% | 75.7% | ||
| Q3 25 | -3.2% | -85.4% | ||
| Q2 25 | 15.0% | -196.0% | ||
| Q1 25 | -50.5% | -452.7% |
| Q4 25 | — | $-3.74 | ||
| Q3 25 | $-0.05 | $-0.11 | ||
| Q2 25 | — | $-0.16 | ||
| Q1 25 | — | $-0.18 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $275.0M | $137.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $379.0M | $35.3M |
| Total Assets | $2.8B | $154.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $275.0M | $137.5M | ||
| Q3 25 | $208.3M | $103.8M | ||
| Q2 25 | $592.5M | $121.6M | ||
| Q1 25 | — | $89.1M |
| Q4 25 | $379.0M | $35.3M | ||
| Q3 25 | $372.0M | $-8.1M | ||
| Q2 25 | $191.4M | $7.1M | ||
| Q1 25 | $186.1M | $10.7M |
| Q4 25 | $2.8B | $154.7M | ||
| Q3 25 | $2.8B | $133.7M | ||
| Q2 25 | $3.0B | $133.8M | ||
| Q1 25 | $2.7B | $103.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.4M | $-2.0M |
| Free Cash FlowOCF − Capex | $24.1M | $-2.1M |
| FCF MarginFCF / Revenue | 89.9% | -15.3% |
| Capex IntensityCapex / Revenue | 16.0% | 0.7% |
| Cash ConversionOCF / Net Profit | 5.32× | -0.19× |
| TTM Free Cash FlowTrailing 4 quarters | $40.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.4M | $-2.0M | ||
| Q3 25 | $24.1M | $-17.5M | ||
| Q2 25 | $-2.3M | $-14.5M | ||
| Q1 25 | $-2.2M | $29.0M |
| Q4 25 | $24.1M | $-2.1M | ||
| Q3 25 | $23.3M | — | ||
| Q2 25 | $-3.3M | $-14.9M | ||
| Q1 25 | $-3.9M | $29.0M |
| Q4 25 | 89.9% | -15.3% | ||
| Q3 25 | 83.2% | — | ||
| Q2 25 | -12.8% | -184.0% | ||
| Q1 25 | -16.9% | 988.3% |
| Q4 25 | 16.0% | 0.7% | ||
| Q3 25 | 3.1% | 0.0% | ||
| Q2 25 | 3.7% | 5.0% | ||
| Q1 25 | 7.2% | 0.8% |
| Q4 25 | 5.32× | -0.19× | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.60× | — | ||
| Q1 25 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
